ALKERMES | ALKS - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.03 1 2026-03
Acadia Pharmaceuticals 10.08 1.53 2026-03
ALKERMES 39.33 19.8 2026-03
Amgen 19.84 5.47 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Gilead Sciences 17.7 2.07 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 24.53 0.91 2026-03
Malin Corporation 11.81 0.72 2023-06
Merck 16.52 2.6 2026-03
Neurocrine Biosciences 28.09 807.38 2026-03
Otsuka Holdings 14.31 2.24 2026-03
Ovoca Bio 1.83 3.29 2024-06
Pfizer 9.32 5.16 2026-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03